Used primarily in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Its unique tricyclic framework with embedded heteroatoms enhances binding affinity to specific neural receptors, making it valuable in developing novel antidepressants and antipsychotics. The compound’s structural rigidity and functional handles allow for selective modifications, improving drug potency and metabolic stability. It is also explored in the design of selective kinase inhibitors for oncology applications due to its ability to mimic purine-binding motifs in enzyme active sites.